{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:59:14Z","timestamp":1792198754673,"version":"4.4.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["223495"],"award-info":[{"award-number":["223495"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203362","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T14:07:45Z","timestamp":1537366065000},"page":"e0203362","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0224-1866","authenticated-orcid":true,"given":"Tania","family":"Schink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Kollhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Varas Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Arf\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Herings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Romio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Schade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.","family":"Schuemie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huub","family":"Straatman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Valkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edeltraut","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"FE Silverstein","year":"2000","journal-title":"Jama"},{"issue":"14","key":"ref2","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","article-title":"Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation: an overview of epidemiologic studies published in the 1990s","volume":"160","author":"S Hernandez-Diaz","year":"2000","journal-title":"Archives of internal medicine"},{"issue":"21","key":"ref3","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"C Bombardier","year":"2000","journal-title":"The New England journal of medicine"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.162.10.1099","article-title":"Nonsteroidal anti-inflammatory drug use and acute myocardial infarction","volume":"162","author":"DH Solomon","year":"2002","journal-title":"Archives of internal medicine"},{"issue":"9326","key":"ref5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0140-6736(02)09350-9","article-title":"Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease","volume":"360","author":"DH Solomon","year":"2002","journal-title":"Lancet"},{"issue":"9301","key":"ref6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(02)07370-1","article-title":"Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study","volume":"359","author":"WA Ray","year":"2002","journal-title":"Lancet"},{"issue":"9339","key":"ref7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(02)11131-7","article-title":"COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease","volume":"360","author":"WA Ray","year":"2002","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"S Trelle","year":"2011","journal-title":"Bmj"},{"issue":"7553","key":"ref9","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"PM Kearney","year":"2006","journal-title":"Bmj"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/pds.3437","article-title":"Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies","volume":"22","author":"C Varas-Lorenzo","year":"2013","journal-title":"Pharmacoepidemiology and drug safety"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/pds.2227","article-title":"Stroke risk and NSAIDs: a systematic review of observational studies","volume":"20","author":"C Varas-Lorenzo","year":"2011","journal-title":"Pharmacoepidemiology and drug safety"},{"issue":"9894","key":"ref12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"N Bhala","year":"2013","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1471-2431-13-192","article-title":"Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?","volume":"13","author":"VE Valkhoff","year":"2013","journal-title":"BMC pediatrics"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating Medication Effects Outside of Clinical Trials: New-User Designs","volume":"158","author":"WA Ray","year":"2003","journal-title":"American journal of epidemiology"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-5-5","article-title":"Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure","volume":"5","author":"V Essebag","year":"2005","journal-title":"BMC medical research methodology"},{"key":"ref16","first-page":"811","article-title":"Pharmacoepidemiology","author":"S Suissa","year":"2005"},{"key":"ref17","first-page":"190","article-title":"A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project","volume":"150","author":"P Avillach","year":"2009","journal-title":"Studies in health technology and informatics"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"RS Bresalier","year":"2005","journal-title":"The New England journal of medicine"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/01.STR.0000226642.55207.94","article-title":"Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study","volume":"37","author":"F Andersohn","year":"2006","journal-title":"Stroke; a journal of cerebral circulation"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.STR.0000053029.45352.A0","article-title":"Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study","volume":"34","author":"S Bak","year":"2003","journal-title":"Stroke; a journal of cerebral circulation"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/STROKEAHA.110.585828","article-title":"Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study","volume":"41","author":"CH Chang","year":"2010","journal-title":"Stroke; a journal of cerebral circulation"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1503\/cmaj.051679","article-title":"Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors","volume":"174","author":"LE Levesque","year":"2006","journal-title":"CMAJ: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/STROKEAHA.107.508549","article-title":"Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke","volume":"39","author":"CL Roumie","year":"2008","journal-title":"Stroke; a journal of cerebral circulation"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00001648-200007000-00004","article-title":"Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women","volume":"11","author":"LA Garcia Rodriguez","year":"2000","journal-title":"Epidemiology"},{"issue":"22","key":"ref25","first-page":"2809","article-title":"Cardiovascular events and COX-2 inhibitors","volume":"286","author":"MA Konstam","year":"2001","journal-title":"Jama"},{"issue":"5","key":"ref26","first-page":"831","article-title":"Selective COX-2 inhibitors, NSAIDs and cardiovascular events\u2014is celecoxib the safest choice?","volume":"3","author":"LG Howes","year":"2007","journal-title":"Therapeutics and clinical risk management"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1715163513481569","article-title":"Cardiovascular risk: Are all NSAIDs alike?","volume":"146","author":"N Pawlosky","year":"2013","journal-title":"Canadian pharmacists journal: CPJ = Revue des pharmaciens du Canada: RPC"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"S Schneeweiss","year":"2005","journal-title":"Journal of clinical epidemiology"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics","volume":"15","author":"S Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiology and drug safety"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T11:09:31Z","timestamp":1540033771000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203362"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Pignataro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203362","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]}}}